SSRI-Induced Hypercholesterolemia in Panic Disorder Patients

Primary Psychiatry

Volumn 10, Issue 12, 2003, Pages 19-

  Ginsberg, David L ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRIACYLGLYCEROL;

AGORAPHOBIA; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERCHOLESTEROLEMIA; PANIC; REVIEW; SOCIAL PHOBIA;

EID: 1842612357     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Weissman MM, Markowitz JS, Oulette R, et al. Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey. Am J Psychiatry. 1990;147:1504-1508.
2. Kawachi I, Sparrow D, Vokonas PS, et al. Symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation. 1994;90:2225-2229.
3. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and the implications for therapy. Cardiology. 1999;99:2192-2217.
4. Hayward C, Taylor CB, Roth WT, et al. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry. 1989;146:917-919.
5. Bajwa WK, Asnis GM, Sanderson WC, et al. High cholesterol levels in patients with panic disorder. Am J Psychiatry. 1992;149:376-378.
6. Agargun MY, Kara H, Algun E, et al. High cholesterol levels in patients with sleep panic. Biol Psychiatry. 1996;40:1064-1065.
7. Bailey DL, Le Melledo J-M. Effects of selective serotonin reuptake inhibitors on cholesterol levels in patients with panic disorder [letter]. J Clin Psychopharmacol. 2003;23:317-318.
8. Liebowitz MR, Mangano RM. Venlafaxine XR in generalized social anxiety disorder. Presented at: the 42nd Annual Meeting of the New Clinical Drug Evaluation Unit; 2002; Boca Raton, FL.
9. Fava M, Judge R, Hoog SL, et al. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. J Clin Psychiatry. 2000;61:863-867.